{"filing":{"accession_number":"0001213900-26-081052","cik":"0001191070","ticker":"NEUP","company_name":"Neuphoria Therapeutics Inc.","form":"8-K","filing_date":"2026-07-23","report_date":"2026-07-20","primary_document":"ea0298914-8k_neuphoria.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1191070/000121390026081052/ea0298914-8k_neuphoria.htm"},"events":[{"id":20227,"run_id":18212,"accession_number":"0001213900-26-081052","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"The filing discloses entry into a material merger agreement on July 23, 2026, whereby Scancell Holdings plc will acquire Neuphoria Therapeutics Inc. in an all-share transaction. The Merger Agreement specifies the exchange ratio (37.77199 ADSs per Neuphoria share), contingent value rights, closing conditions, and termination rights. This is a change-of-control transaction creating a combined company, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and constituting material M\u0026A activity.","company_name":"Neuphoria Therapeutics Inc.","ticker":"NEUP","filing_date":"2026-07-23","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":19529,"accession_number":"0001213900-26-081052","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses entry into a material merger agreement on July 23, 2026, whereby Scancell Holdings plc will acquire Neuphoria Therapeutics Inc. in an all-share transaction. The Merger Agreement specifies the exchange ratio (37.77199 ADSs per Neuphoria share), contingent value rights, closing conditions, and termination rights. This is a change-of-control transaction creating a combined company, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and constituting material M\u0026A activity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T10:04:06.313207+00:00","company_name":"Neuphoria Therapeutics Inc.","ticker":"NEUP","filing_date":"2026-07-23"}]}